In 2023, CMS estimates Americans with Medicare Part D prescription drug coverage spent $3.9 billion out-of-pocket for the 10 drugs. SOURCES Centers for Medicare & Medicaid Services.

List price in 2023 for a 30-day supply was $556, new list price will be $178.50, down 68%. Enbrel The Immunex Corporation's Enbrel treats rheumatoid arthritis, psoriasis and psoriatic arthritis.